Substrate Preference of Transglutaminase 2 Revealed by Logistic Regression Analysis and Intrinsic Disorder Examination

Journal of Molecular Biology

Volumn 383, Issue 2, 2008, Pages 390-402

  Csosz, Eva ^a   Bagossi, Peter ^a   Nagy, Zoltan ^a   Dosztanyi, Zsuzsanna ^b   Simon, Istvan ^b   Fesus, Laszlo ^a,b  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

3D structure; glutamine and lysine site; IUP; substrate preference; TG2

Indexed keywords

GLUTAMINE; LYSINE; POLYPEPTIDE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CRYSTAL STRUCTURE; IN VITRO STUDY; LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; VALIDATION PROCESS;

EID: 52949151510     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmb.2008.08.026     Document Type: Article

References (50)

1. Lorand L., and Graham R.M. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat. Rev., Mol. Cell Biol. 4 (2003) 140-156
2. Aeschlimann D., and Paulsson M. Transglutaminases: protein cross-linking enzymes in tissues and body fluids. Thromb. Haemostasis. 71 (1994) 402-415
3. Folk J.E., and Finlayson J.S. The epsilon(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem. 31 (1977) 1-133
4. Griffin M., Casadio R., and Bergamini C.M. Transglutaminases: nature's biological glues. Biochem. J. 368 (2002) 377-396
5. Fésüs L., and Piacentini M. Transglutaminase 2: an enigmatic enzyme with diverse functions. Trends Biochem. Sci. 27 (2002) 534-539
6. Esposito C., and Caputo I. Mammalian transglutaminases: identification of substrates as a key to physiological function and physiopathological relevance. FEBS J. 272 (2005) 615-631
7. Kim Y., Park Y.W., Lee Y.S., and Jeoung D. Hyaluronic acid induces transglutaminase II to enhance cell motility; role of Rac1 and FAK in the induction of transglutaminase II. Biotechnol. Lett. 30 (2008) 31-39
8. Park S.S., Kim J.M., Kim D.S., Kim I.H., and Kim S.Y. Transglutaminase 2 mediates polymer formation of I-kappaBalpha through C-terminal glutamine cluster. J. Biol. Chem. 281 (2006) 34965-34972
9. Ando Y., Imamura S., Owada M.K., and Kannagi R. Calcium-induced intracellular cross-linking of lipocortin I by tissue transglutaminase in A431 cells. Augmentation by membrane phospholipids. J. Biol. Chem. 266 (1991) 1101-1108
10. Fésüs L., and Szondy Z. Transglutaminase 2 in the balance of cell death and survival. FEBS Lett. 579 (2005) 3297-3302
11. Pirreda L., Amendola A., Colizzi V., Davies P.J.A., Farrace M.G., Fraziano M., et al. Lack of tissue transglutaminase protein cross-linking leads to leakage of macromolecules from dying cells, relationship to development of autoimmunity in MRLlpr/lpr mice. Cell Death Differ. 4 (1997) 463-472
12. Kim S.Y., Marekov L., Bubber P., Browne S.E., Stavrovskaya I., Lee J., et al. Mitochondrial aconitase is a transglutaminase 2 substrate, transglutamination is a probable mechanism contributing to high-molecular-weight aggregates of aconitase and loss of aconitase activity in Huntington disease brain. Neurochem. Res. 30 (2005) 1245-1255
13. Cooper A.J., Sheu K.R., Burke J.R., Onodera O., Strittmatter W.J., Roses A.D., and Blass J.P. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc. Natl Acad. Sci. USA 94 (1997) 12604-12609
14. Nemes Z., Devreese B., Steinert P.M., Van Beeumen J., and Fésüs L. Cross-linking of ubiquitin, HSP27, parkin and α-synuclein by γ-glutamyl-e{open}-lysine bonds in Alzheimer's neurofibrillary tangles. FASEB J. 18 (2004) 1135-1137
15. Lesort M., Attanavanich K., Zhang J., and Johnson G.V. Distinct nuclear localization and activity of tissue transglutaminase. J. Biol. Chem. 273 (1998) 11991-11994
16. Kim J.H., Nam K.H., Kwon O.S., Kim I.G., Bustin M., Choy H.E., and Park S.C. Histone cross-linking by transglutaminase. Biochem. Biophys. Res. Commun. 293 (2002) 1453-1457
17. Han J.A., and Park S.C. Transglutaminase-dependent modulation of transcription factor Sp1 activity. Mol. Cell 10 (2000) 612-618
18. Oliverio S., Amendola A., Di Sano F., Farrace M.G., Fésüs L., Nemes Z., et al. Tissue transglutaminase-dependent posttranslational modification of the retinoblastoma gene product in promonocytic cells undergoing apoptosis. Mol. Cell. Biol. 10 (1997) 6040-6048
19. Keresztessy Z., Cso{double acute}sz E., Hársfalvi J., Csomós K., Gray J., Lightowlers R.N., et al. Phage display selection of efficient glutamine-donor substrate peptides for transglutaminase 2. Protein Sci. 15 (2006) 2466-2480
20. Aeschlimann D., and Thomazy V. Protein crosslinking in assembly and remodeling of extracellular matrices: the role of transglutaminases. Connect. Tissue Res. 41 (2000) 1-27
21. Kaartinen M.T., El-Maadawy S., Räsänen N.H., and McKee M.D. Tissue transglutaminase and its substrates in bone. J. Bone Miner. Res. 17 (2002) 2161-2173
22. Kaartinen M.T., Sun W., Kaipatur N., and McKee M.D. Transglutaminase crosslinking of SIBLING proteins in teeth. J. Dent. Res. 84 (2005) 607-612
23. Cso{double acute}sz E., Meskó B., and Fésüs L. Transdab wiki: the interactive transglutaminase substrate database on web 2.0 surface. Amino Acids (2008) Jul 2. Epub ahead of print
24. Sugimura Y., Hosono M., Wada F., Yoshimura T., Maki M., and Hitomi K. Screening for the preferred substrate sequence of transglutaminase using a phage-displayed peptide library: identification of peptide substrates for TGASE 2 and Factor XIIIA. J. Biol. Chem. 281 (2006) 17699-17706
25. Pastor M.T., Diez A., Perez-Paya E., and Abad C. Addressing substrate glutamine requirements for tissue transglutaminase using substance P analogues. FEBS Lett. 451 (1999) 231-234
26. Grootjans J.J., Groenen P.J.T.A., and de Jong W.W. Substrate requirements for transglutaminases: influence of the amino acid preceding the amine donor lysine in a native protein. J. Biol. Chem. 270 (1995) 22855-22858
27. Groenen P.J., Smulders R.H., Peters R.F., Grootjans J.J., van den Ijssel P.R., Bloemendal H., and de Jong W.W. The amine-donor substrate specificity of tissue-type transglutaminase. Influence of amino acid residues flanking the amine-donor lysine residue. Eur. J. Biochem. 220 (1994) 795-799
28. Gorman J.J., and Folk J.E. Structural features of glutamine substrates for transglutaminases. Specificities of human plasma factor XIIIa and the guinea pig liver enzyme toward synthetic peptides. J. Biol. Chem. 256 (1981) 2712-2715
29. Gorman J.J., and Folk J.E. Structural features of glutamine substrates for transglutaminases. Role of extended interactions in the specificity of human plasma factor XIIIa and of the guinea pig liver enzyme. J. Biol. Chem. 259 (1984) 9007-9010
30. Aeschlimann D., Paulsson M., and Mann K. Identification of Gln726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. J. Biol. Chem. 267 (1992) 11316-11321
31. Coussons P.J., Price N.C., Kelly S.M., Smith B., and Sawyer L. Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides. Biochem. J. 282 (1992) 929-930
32. Altman D.G. Practical Statistics for Medical Research (1992), Chapman & Hall 351-388
33. Asgary M.P., Jahandideh S., Abdolmaleki P., and Kazemnejad A. Analysis and identification of beta-turn types using multinomial logistic regression and artificial neural network. Bioinformatics 23 (2007) 3125-3130
34. Kitahara A., Mikawa H., Ohtsuki H., Yamagata Y., Murachi T., and Kannagi R. Specific localization of tissue-type transglutaminase in adrenocorticotropin-producing cells of the human pituitary gland as demonstrated by immunohistochemistry. J. Clin. Endocrinol. Metab. 65 (1987) 885-890
35. Tompa P. The interplay between structure and function in intrinsically unstructured proteins. FEBS Lett. 579 (2005) 3346-3354
36. Dosztányi Z., Csizmok V., Tompa P., and Simon I. The pairwise energy content estimated from amino acid composition discriminates between folded and intrinsically unstructured proteins. J. Mol. Biol. 347 (2005) 827-839
37. Peng K., Radivojac P., Vucetic S., Dunker A.K., and Obradovic Z. Length-dependent prediction of protein intrinsic disorder. BMC Bioinformatics 7 (2006) 208
38. Fontana A., Spolaore B., Mero A., and Veronese F.M. Site-specific modification and PEGylation of pharmaceutical proteins mediated by transglutaminase. Adv. Drug Delivery Rev. 60 (2008) 13-28
39. Hanson E.S., and Dallman M.F. Neuropeptide Y (NPY) may integrate responses of hypothalamic feeding systems and the hypothalamo-pituitary-adrenal axis. J. Neuroendocrinol. 7 (1995) 273-279
40. Sakurai T., Amemiya A., Ishii M., Matsuzaki I., Chemelli R.M., Tanaka H., et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 92 (1998) 573-585
41. Siegel J.M. Narcolepsy: a key role for hypocretins (orexins). Cell 98 (1999) 409-412
42. Heine R.J., Van Gaal L.F., Johns D., Mihm M.J., Widel M.H., Brodows R.G., and GWAA Study Group. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial. Ann. Intern. Med. 143 (2005) 559-569
43. Uversky V.N. Natively unfolded proteins: a point where biology waits for physics. Protein Sci. 11 (2002) 739-756
44. Tompa P., and Fuxreiter M. Fuzzy complexes: polymorphism and structural disorder in protein-protein interactions. Trends Biochem. Sci. 33 (2008) 2-8
45. Iakoucheva L.M., Radivojac P., Brown C.J., O'Connor T.R., Sikes J.G., Obradovic Z., and Dunker A.K. The importance of intrinsic disorder for protein phosphorylation. Nucleic Acids Res. 32 (2004) 1037-1049
46. Khan A.N., and Lewis P.N. Unstructured conformations are a substrate requirement for the Sir2 family of NAD-dependent protein deacetylases. J. Biol. Chem. 280 (2005) 36073-36078
47. Hevessy Z., Patthy A., Kárpáti L., and Muszbek L. Alpha(2)-plasmin inhibitor is a substrate for tissue transglutaminase: an in vitro study. Thromb. Res. 99 (2000) 399-406
48. Ahmad S., Gromiha M., Fawareh H., and Sarai A. ASAView, solvent accessibility graphics for proteins. BMC Bioinformatics 5 (2004) 51
49. SPSS 15.0 for Windows (2006). SPSS Inc.
50. Humphrey W., Dalke A., and Schulten K. VMD-visual molecular dynamics. J. Mol. Graphics 14 (1996) 33-38